Značaj kognitivnih strategija emocionalne regulacije za kvalitet života obolelih od karcinoma dojke

  • Aleksandra Kovač Institut za onkologiju Vojvodine
  • Snežana Tovilović Universtiy of Novi Sad, Faculty of Philosophy, Novi Sad, Serbia
  • Vojislava Bugarski Ignjatović Clinical Center of Vojvodina, Clinic for Neurology, Novi Sad, Serbia
  • Svetlana Popović-Petrović University of Novi Sad, Faculty of Medicine, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia
  • Milanka Tatić University of Novi Sad, Faculty of Medicine, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia
Ključne reči: dojka, neoplazme, kvalitet života, kognitivna terapija, lečenje, ishod

Sažetak


Uvod/Cilj. Karcinom dojke je oboljenje koje je često praćeno neprijatnim emocionalnim stanjima bolesnica i emocionalnim distresom, što značajno može da utiče kako na proces lečenja, tako i na kvalitet života obolelih. Stoga je cilj ove studije bio da ispita potencijalnu medijacionu ulogu strategija kognitivne emocionalne regulacije u relaciji između emocionalnog distresa i različitih aspekata kvaliteta života obolelih, što bi dalje indikovalo potencijalne psihoterapijske intervencije u kliničkoj psihoonkološkoj praksi. Metode. Istraživanje je dizajnirano kao studija preseka, u kojoj je učestvovalo 97 bolesnica sa dijagnozom karcinoma dojke. Emocionalni distres meren je Skalom depresivnosti, anksioznosti i stresa (DASS-21). Strategije kognitivne emocionalne regulacije merene su Upitnikom kognitivno emocionalne regulacije (CERQ-36), dok su različiti aspekti kvaliteta života procenjeni Upitnikom funkcionalne procene terapije karcinoma (FACT-B). Za utvrđivanje multiple simultane medijacije između varijabli korišćen je program makro INDIRECT za SPSS. Rezultati. Pozitivnim refokusiranjem bili su ostvareni pozitivni efekti kako na telesno [a = -0,83, b = 0,50, ab = -0,42, standard error (SE) = 0,14; 95% confidence interval (CI) = 0,17 – 0.83], tako i na emocionalno blagostanje bolesnica (a = -0,83, b = 0,29, ab = 0,24, SE = 0,13; 95% CI = -0,01 – 0,58). Ruminacije su se negativno odražavale na emocionalno blagostanje (a = -0,75, b = -0,33, ab = -0,25, SE = 0,16; 95% CI = -0,71 –   -0,01) bolesnica. Katastrofiziranjem je bio ostvaren negativan uticaj na socijalno (a = 0,96, b = 0,12, ab = -0,12, SE = 0,13; 95% CI = -0,33 – -0,13) i funkcionalno blagostanje bolesnica (a = 0,96, b = -0,16, ab = -0,15, SE = 0,09; 95% CI = -0,32 – -0,01). Zaključak. Pozitivno refokusiranje, ruminacija i katastrofiziranje predstavljaju značajne kognitivne strategije prevladavanja posredstvom kojih se značajno menja intenzitet emocionalnog distresa, što se potom odražava i na različite aspekte kvaliteta života obolelih. Navedeno implicira potencijalne koristi od uvođenja kognitivno-bihejvioralnih intervencija, usmerenih na usvajanje adaptivnih strategija kognitivne regulacije afekta, a u cilju pospešivanja kvaliteta života obolelih od karcinoma dojke.

Reference

Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 2012; 141 (2–3): 343–51.

Carlson LE, Waller A, Groff SL, Giese-Davis J, Bultz BD. What goes up does not always come down: Patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology 2013; 22(1): 168–76.

Howell D, Olsen K. Distress – the 6th vital sign. Curr Oncol 2011; 18(5): 208–10.

Andersen BL., Rowland JH, Somerfield, MR. Screening, assess-ment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guide-line adaptation. J Oncol Pract 2015; 11(2): 133–4.

Andreu Y, Galdón MJ, Durá E, Martínez P, Pérez S, Murgui S. A longitudinal study of psychosocial distress in breast cancer: Prevalence and risk factors. Psychol Health 2012; 27(1): 72–87.

Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance J Urol 2007; 178(3 Pt 1): 826–31; discussion 831–2.

Pinquart M, Duberstein PR. Depression and cancer mortality: A meta-analysis. Psychol Med 2010; 40(11): 1797–810.

Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depres-sive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 can-cer survivors from the profiles registry. J Cancer Surviv 2013; 7(3): 484–92.

Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110(1): 9–17.

Cella DF. Quality of life: concepts and definition. J Pain Symptom Manage 1994; 9(3): 186–92.

Brandao T, Tavares R, Schulz MS, Matos PM. Measuring emo-tion regulation and emotional expression in breast cancer pa-tients: A systematic review. Clin Psychol Rev 2016; 43: 114–27.

Gross JJ. The emerging field of emotion regulation: An integra-tive review. Rev Gen Psychol 1998; 2(3): 271–99.

Webb, TL, Miles E, Sheeran P. Dealing with feeling: A meta-analysis of the effectiveness of strategies derived from the process model of emotion regulation. Psychol Bull 2012; 138(4): 775–808.

Conley CC, Bishop BT, Andersen BL. Emotions and emotion regulation in breast cancer survivorship. Healthcare (Basel) 2016; 4(3): pii: E56.

Garnefski N, Kraaij V, Spinhoven P. Negative life events, cogni-tive emotion regulation and emotional problems. Pers Individ Dif 2001; 30(8):1311–27.

Garnefski N, Kraaij V. The cognitive emotion regulation ques-tionnaire: Psychometric features and prospective relationship with depression and anxiety an adults. Eur J Psychol Assess 2007; 23(3): 141‒9.

Ochsner KN, Gross JJ. Cognitive emotion regulation: Insights from social cognitive and affective neuroscience. Curr Dir Psy¬chol Sci 2008; 17(2): 153‒8.

Schroevers M, Kraaij V, Garnefski N. How do cancer patients manage unattainable personal goals and regulate their emo-tions. Br J Health Psychol 2008; 13(Pt 3): 551–62.

Mauss IB, Bunge AS, Gross JJ. Automatic emotion regulation. Soc Personal Psychol Compass 2007; 1(1): 146–67.

Wang Y, Yi J, He J, Chen G, Li L, Yang Y, Zhu X. Cognitive emotion regulation strategies as predictors of depressive symp-toms in women newly diagnosed with breast cancer. Psy-chooncology 2014; 23(1): 93–9.

Li L, Zhu X, Yang Y, He J, Yi J, Wang Y, Zhang, J. Cognitive emotion regulation: Characteristics and effect on quality of life in women with breast cancer. Health Qual Life Outcomes 2015; 13: 51.

Jovanović V, Gavrilović-Jerković V, Žuljević D, Brdarić D. Psycho-metric evaluation of the depression anxiety stress Scales – 21 (DASS–21) in a Serbian student sample. Psihologija 2014; 47(1): 93–112.

Garnefski N, Kraaij V, Spinhoven P. Manual for the use of the Cognitive Emotion Regulation Questionnaire. Leiderdor, The Netherlands: DATEC; 2002.

Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin On-col 1997; 15(3): 974–86.

Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple media-tor models". Behav Res Methods 2008; 40(3): 879–91.

Daniels, S. Cognitive Behavior Therapy for Patients With Cancer. J Adv Pract Oncol 2015; 6(1): 54–6.

Elomaa M, Decwilliams A, Kalso E. Attention management as a treatment for chronic pain. Eur J Pain 2009; 13(10):1062–7.

Popov S. Relation of cognitive emotional regulation, personality traits and affec-tivity. Primenjena psihologija 2010; 1: 59–76. (Serbian)

Roelofs J, Rood L, Meesters C, Dorsthorst V, Bögels S, Alloy L, et al. The influence of rumination and distraction on depressed and anxious mood: a prospective examination of the response styles theory in children and adolescents. Eur Child Adolesc Psychiatry 2009; 18(10):635–42.

Soo H, Sherman KA. Rumination, psychological distress and post-traumatic growth in women diagnosed with breast can-cer. Psychooncology 2015; 24(1): 70–9.

Nolen-Hoeksema S, Wisco BE, Lyubomirsky S. Rethinking rumi-nation. Perspect Psychol Sci 2008; 3(5): 400–24.

Farb NA, Anderson AK, Bloch RT, Segal ZV. Mood-linked re-sponses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression. Biol Psychiatry 2011; 70(4): 366–72.

Alloy LB, Abramson LY, Whitehouse WG, Hogan ME, Tashman NA, Steinberg DL, et al. Depressogenic cognitive styles: Pre-dictive validity, information processing and personality char-acteristics, and developmental origins. Behav Res Ther 1999; 37(6): 503–31.

Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother 2009; 9(5): 745–58.

Jaracz J, Gattner K, Jaracz K, Górna K. Unexplained Painful Physical Symptoms in Patients with Major Depressive Disor-der: Prevalence, Pathophysiology and Management. CNS Drugs 2016; 30(4): 293–304.

Steger M, Kashdan T. Depression and Everyday Social Activity, Belonging, and Well-Being. J Couns Psychol 2009; 56(2): 289–300.

Watkins ER, Scott J, Wingrove J, Rimes KA, Bathurst N, Steiner H, et al. Rumination-focused cognitive behaviour therapy for residual depression: A case series. Behav Res Ther 2007, 45(9): 2144–54.

Watkins ER. Depressive rumination: investigating mechanisms to improve cognitive-behavioral treatments. Cogn Behav Ther 2009; 38(Suppl 1): 8–14.

van der Lee ML, Garssen B. Mindfulness-based cognitive thera-py reduces chronic cancer-related fatigue: a treatment study. Psychooncology 2012; 21(3): 264–72.

Johannsen M, O'Connor M, O'Toole MS, Jensen AB, Zachariae R. Mindfulness-based cognitive therapy and persistent pain in women treated for primary breast cancer: exploring possible statistical mediators - results from a randomized controlled trial. Clin J Pain 2018; 34(1): 59–67.

Wolgast M, Lundh LG. Is Distraction an Adaptive or Maladap-tive Strategy for Emotion Regulation? A Person-Oriented Approach. J Psychopathol Behav Assess 2017; 39(1): 117–27.

Brothers B, Yang H, Strunk DR, Andersen BL. Cancer patients with major depressive disorder: Testing a biobehavior-al/cognitive behavior intervention. J Consult Clin Psychol 2011; 79(2): 253–60.

Groarke A, Curtis R, Kerin M. Cognitive‐behavioural stress management enhances adjustment in women with breast can-cer. Br Journal Health Psychol 2013; 18(3): 623–41.

Tatrow K, Montgomery GH. Cognitive behavioral therapy tech-niques for distress and pain in breast cancer patients: A meta-analysis. J Behav Med 2006; 29(1): 17–27.

Sandler CX, Goldstein DA, Horsfield S, Bennett BK, Friedlander M, Bastick P A, et al. Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. J Pain Symptom Manage 2017; 54(1): 74–84.

Stagl JM, Bouchard LC, Lechner SC, Blomberg BB, Gudenkauf LM, Jutagir DR, et al. Long term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial. Cancer 2015; 121(11): 1873–81.

Garnefski N, Teerds J, Kraaij V, Legerstee J, van den Kommer T. Cognitive emotion regulation strategies and depressive symp-toms: Differences between males and females. Pers Individ Dif 2004; 36(2): 267–76.

You J, Wang C, Rodriguez L, Wang X, Lu Q. Personality, coping strategies and emotional adjustment among Chinese cancer pa-tients of different ages. Eur J Cancer Care 2018; 27(1): doi: 10.1111/ecc.12781.

Objavljeno
2021/02/11
Rubrika
Originalni članak